Therapeutic Asset Ratings
166 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Veliparib
Non-Small -Cell Lung Cancer
AbbVie
P3
BBB
(74)
Abbv-951
Parkinson's Disease (PD)
AbbVie
P3
BB
(71)
Hycamtin
Small Cell Lung Cancer
AbbVie
P4
BB
(70)
Mirvetuximab Soravtansine
Fallopian Tube Cancer
AbbVie
P3
BB
(70)
Mirvetuximab Soravtansine
Primary Peritoneal Cancer
AbbVie
P3
BB
(70)
Mirvetuximab Soravtansine
Peritoneal Cancer
AbbVie
P3
BB
(68)
(+)-VINCRISTINE
Fallopian Tube Cancer
AbbVie
P3
BB
(68)
(+)-VINCRISTINE
Primary Peritoneal Cancer
AbbVie
P3
BB
(68)
Carboplatin
Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer
AbbVie
P2/3
BB
(68)
Vinorelbine
Lung Squamous Cell Carcinoma
AbbVie
P3
BB
(67)
Veliparib
Lung Squamous Cell Carcinoma
AbbVie
P3
BB
(66)
Irinotecan
Malignant Female Reproductive System Neoplasm
AbbVie
P2
BB
(65)
(+)-VINCRISTINE
Malignant Female Reproductive System Neoplasm
AbbVie
P2
BB
(65)
Galicaftor
Cystic Fibrosis
AbbVie
P2
BB
(64)
Mirvetuximab Soravtansine
Ovarian Cancer
AbbVie
P3
B
(61)
Emraclidine
Schizophrenia
AbbVie
P2
B
(61)
Venetoclax
Waldenstrom Macroglobulinemia
AbbVie
P2
B
(61)
Veliparib
Ovarian Cancer
AbbVie
P3
B
(60)
Olaparib
Gynaecological Cancers
AbbVie
P2
B
(60)
AMRUBICIN
Small Cell Lung Cancer
AbbVie
P3
B
(59)
Telisotuzumab Adizutecan
Colorectal Cancer
AbbVie
P3
B
(58)
Navocaftor
Cystic Fibrosis
AbbVie
P2
B
(58)
Immunoglobulin G4 [234-proline], anti-(human protein GARP-transforming growth factor ?1 complex) (human monoclonal ABBV-151 ?4-chain), disulfide with human monoclonal ABBV-151 ?-chain, dimer
Hepatocellular Carcinoma
AbbVie
P2/3
B
(58)
Venetoclax
Cancer
AbbVie
P3
B
(57)
Abbv-552
Alzheimer's Disease (AD)
AbbVie
P2
B
(57)
Showing 1 to 25 of 166 assets
Previous
Page 1 of 7
Next
